These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20348281)

  • 1. Fibroblast-specific expression of AC6 enhances beta-adrenergic and prostacyclin signaling and blunts bleomycin-induced pulmonary fibrosis.
    Liu X; Li F; Sun SQ; Thangavel M; Kaminsky J; Balazs L; Ostrom RS
    Am J Physiol Lung Cell Mol Physiol; 2010 Jun; 298(6):L819-29. PubMed ID: 20348281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenylyl cyclase type 6 overexpression selectively enhances beta-adrenergic and prostacyclin receptor-mediated inhibition of cardiac fibroblast function because of colocalization in lipid rafts.
    Liu X; Thangavel M; Sun SQ; Kaminsky J; Mahautmr P; Stitham J; Hwa J; Ostrom RS
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):359-69. PubMed ID: 17934720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts.
    Liu X; Ostrom RS; Insel PA
    Am J Physiol Cell Physiol; 2004 May; 286(5):C1089-99. PubMed ID: 15075208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
    Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
    J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase.
    Swaney JS; Roth DM; Olson ER; Naugle JE; Meszaros JG; Insel PA
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):437-42. PubMed ID: 15625103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production.
    Clark JG; Kostal KM; Marino BA
    J Clin Invest; 1983 Dec; 72(6):2082-91. PubMed ID: 6196378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenylyl cyclase 2 selectively couples to E prostanoid type 2 receptors, whereas adenylyl cyclase 3 is not receptor-regulated in airway smooth muscle.
    Bogard AS; Adris P; Ostrom RS
    J Pharmacol Exp Ther; 2012 Aug; 342(2):586-95. PubMed ID: 22619251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II enhances adenylyl cyclase signaling via Ca2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts.
    Ostrom RS; Naugle JE; Hase M; Gregorian C; Swaney JS; Insel PA; Brunton LL; Meszaros JG
    J Biol Chem; 2003 Jul; 278(27):24461-8. PubMed ID: 12711600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IGF-1 pathway in lung fibroblast activation.
    Hung CF; Rohani MG; Lee SS; Chen P; Schnapp LM
    Respir Res; 2013 Oct; 14(1):102. PubMed ID: 24103846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis.
    Lawson WE; Polosukhin VV; Zoia O; Stathopoulos GT; Han W; Plieth D; Loyd JE; Neilson EG; Blackwell TS
    Am J Respir Crit Care Med; 2005 Apr; 171(8):899-907. PubMed ID: 15618458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrotic lung fibroblasts show blunted inhibition by cAMP due to deficient cAMP response element-binding protein phosphorylation.
    Liu X; Sun SQ; Ostrom RS
    J Pharmacol Exp Ther; 2005 Nov; 315(2):678-87. PubMed ID: 16079300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
    De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
    Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of collagen production following bleomycin-induced pulmonary fibrosis in hamsters. Presence of a factor in lung that increases fibroblast prostaglandin E2 and cAMP and suppresses fibroblast proliferation and collagen production.
    Clark JG; Kostal KM; Marino BA
    J Biol Chem; 1982 Jul; 257(14):8098-105. PubMed ID: 6177695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix proteins: a positive feedback loop in lung fibrosis?
    Blaauboer ME; Boeijen FR; Emson CL; Turner SM; Zandieh-Doulabi B; Hanemaaijer R; Smit TH; Stoop R; Everts V
    Matrix Biol; 2014 Feb; 34():170-8. PubMed ID: 24291458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
    Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.
    Dackor RT; Cheng J; Voltz JW; Card JW; Ferguson CD; Garrett RC; Bradbury JA; DeGraff LM; Lih FB; Tomer KB; Flake GP; Travlos GS; Ramsey RW; Edin ML; Morgan DL; Zeldin DC
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L645-55. PubMed ID: 21856819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by adrenomedullin.
    Kach J; Sandbo N; Sethakorn N; Williams J; Reed EB; La J; Tian X; Brain SD; Rajendran K; Krishnan R; Sperling AI; Birukov K; Dulin NO
    Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L757-64. PubMed ID: 23585227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
    Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
    Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis.
    Zhang HY; Gharaee-Kermani M; Zhang K; Karmiol S; Phan SH
    Am J Pathol; 1996 Feb; 148(2):527-37. PubMed ID: 8579115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.